An open-label study of the safety of Fuzeon plus free choice of antiretroviral therapy in patients with advanced HIV disease and previous multidrug experience who have no viable treatment regimen.

Trial Profile

An open-label study of the safety of Fuzeon plus free choice of antiretroviral therapy in patients with advanced HIV disease and previous multidrug experience who have no viable treatment regimen.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2010

At a glance

  • Drugs Antiretrovirals; Enfuvirtide
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 26 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top